Opinion

Antonio Giordano: First step towards deescalation of surgery for breast cancer

Antonio Giordano and Henry M. Kuerer

Apr 1, 2025, 08:15

Antonio Giordano: First step towards deescalation of surgery for breast cancer

Antonio Giordano, Breast Medical Oncologist at Dana-Farber Cancer Institute, shared post on X:

“In patients who achieved pCR with NACT, the ipsilateral breast tumor recurrence rate was 0%, and disease-free and overall survival rates were 100% for patients without breast surgery.

First step towards deescalation of Surgery for breast cancer.”

Selective Elimination of Breast Surgery for Invasive Breast Cancer: A Nonrandomized Clinical Trial

Authors: Henry M Kuerer et al.

Antonio Giordano

Anthony Lucci Antonio Giordano Benjamin D Smith Breast Cancer breast cancer surgery cancer Emilia J Diego Gaiane M Rauch Heather Lin Helen M. Johnson Henry M. Kuerer invasive breast cancer Judy C. Boughey Kelly K. Hunt Melissa P Mitchell OncoDaily Oncology Richard L White Savitri Krishnamurthy Simona F Shaitelman Vicente Valero Wei T Yang Yu Shen

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

Highlights from ELCC 2025

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

Meet the New AACR Board of Directores for 2025-2028 Term

Do Artificial Sweeteners Cause Cancer? Myths and Facts